Risperidone (RSP) is an atypical antipsychotic drug widely used to treat schizophrenia\nand bipolar disorder. Nanoparticles (NPs) are being developed as in vivo targeted drug delivery\nsystems, which cross the blood-brain barrier and improve pharmacokinetics and drug effectiveness.\nHere, biodegradable proteinoids were synthesized by thermal step-growth polymerization from the\namino acids l-glutamic acid, l-phenylalanine and l-histidine and poly (l-lactic acid). Proteinoid NPs\ncontaining RSP were then formed by self-assembly..................................
Loading....